The average analysts' target price is $232.00 for United Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, United Therapeutics is ranked 131.
United Therapeutics rank is 133
|Top Industry Values
United Therapeutics rank is 259
|Up EPS Surprise
United Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
|90 Day Gain
United Therapeutics rank is 3214
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, United Therapeutics is ranked 104.
|10 Day Loss
United Therapeutics rank is 398